Biomarker Insights is a peer-reviewed, open-access research journal where those engaged in biomarker research can turn for rapid communication of the latest advances in the application of biomarkers toward the discovery of new knowledge, and toward the clinical translation of that knowledge to increase the efficacy of practicing clinicians. Papers submitted for review in Biomarker Insights should focus on the following areas:

• Biomarkers as tools in decision making
• Regulatory acceptance of biomarkers
• Biomarker development and validation
• Role of collaborations and consortia in biomarker advancement
• The "Economics" Behind Personalized Medicine and Pharmacogenomics
• Toxicity biomarkers, toxicogenomics
• Biomarkers for early efficacy assessment
• Genetic biomarkers; genomic biomarkers
• Metabolomic biomarkers
• Pathway analysis
• Biomarkers in clinical pharmacology
• Biomarkers for clinical safety assessment
• Clinical pharmacogenomics